MPP+-induces PUMA- and p53-dependent, but ATF3-independent cell death

Toxicology Letters

Volumn 219, Issue 2, 2013, Pages 93-98

  Bernstein, Alison I ^a   O'Malley, Karen L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ATF3; MPP+; P53; Parkinson's; PUMA; UPR

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; ACTIVATING TRANSCRIPTION FACTOR 3; PROTEIN P53; PUMA PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL STRESS; ENDOPLASMIC RETICULUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNFOLDED PROTEIN RESPONSE; UPREGULATION; WILD TYPE;

1-METHYL-4-PHENYLPYRIDINIUM; ACTIVATING TRANSCRIPTION FACTOR 3; ANIMALS; APOPTOSIS REGULATORY PROTEINS; CELL DEATH; CELLS, CULTURED; DNA DAMAGE; DOPAMINE AGENTS; GENES, P53; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR CHAPERONES; PARKINSON DISEASE, SECONDARY; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEINS; UNFOLDED PROTEIN RESPONSE; UP-REGULATION;

ANIMALIA; MUS;

EID: 84876315625     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2013.03.003     Document Type: Article

References (40)

1. Antenor-Dorsey J.A., O'Malley K.L. WldS but not Nmnat1 protects dopaminergic neurites from MPP+ neurotoxicity. Molecular Neurodegeneration 2012, 7:5.
2. Bernstein A.I., Garrison S.P., Zambetti G.P., O'Malley K.L. 6-OHDA generated ROS induces DNA damage and p53- and PUMA-dependent cell death. Molecular Neurodegeneration 2011, 6:2.
3. Blum D., Torch S., Lambeng N., Nissou M., Benabid A.L., Sadoul R., Verna J.M. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Progress in Neurobiology 2001, 65:135-172.
4. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
5. Duan W., Zhu X., Ladenheim B., Yu Q.S., Guo Z., Oyler J., Cutler R.G., Cadet J.L., Greig N.H., Mattson M.P. p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism. Annals of Neurology 2002, 52:597-606.
6. Egawa N., Yamamoto K., Inoue H., Hikawa R., Nishi K., Mori K., Takahashi R. The endoplasmic reticulum stress sensor, ATF6alpha, protects against neurotoxin-induced dopaminergic neuronal death. Journal of Biological Chemistry 2011, 286:7947-7957.
7. Eriksen J.L., Wszolek Z., Petrucelli L. Molecular pathogenesis of Parkinson disease. Archives of Neurology 2005, 62:353-357.
8. Hartman M.G., Lu D., Kim M.L., Kociba G.J., Shukri T., Buteau J., Wang X., Frankel W.L., Guttridge D., Prentki M., Grey S.T., Ron D., Hai T. Role for activating transcription factor 3 in stress-induced beta-cell apoptosis. Molecular and Cellular Biology 2004, 24:5721-5732.
9. Hasbani D.M., Perez F.A., Palmiter R.D., O'Malley K.L. Dopamine depletion does not protect against acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in vivo. Journal of Neuroscience 2005, 25:9428-9433.
10. Hashida K., Kitao Y., Sudo H., Awa Y., Maeda S., Mori K., Takahashi R., Iinuma M., Hori O. ATF6alpha promotes astroglial activation and neuronal survival in a chronic mouse model of Parkinson's disease. PLoS ONE 2012, 7:e47950.
11. Hetz C., Glimcher L. The daily job of night killers: alternative roles of the BCL-2 family in organelle physiology. Trends in Cell Biology 2008, 18:38-44.
12. Holtz W.A., O'Malley K.L. Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. Journal of Biological Chemistry 2003, 278:19367-19377.
13. Jacks T., Remington L., Williams B.O., Schmitt E.M., Halachmi S., Bronson R.T., Weinberg R.A. Tumor spectrum analysis in p53-mutant mice. Current Biology 1994, 4:1-7.
14. Jeffers J.R., Parganas E., Lee Y., Yang C., Wang J., Brennan J., MacLean K.H., Han J., Chittenden T., Ihle J.N., McKinnon P.J., Cleveland J.L., Zambetti G.P. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 2003, 4:321-328.
15. Jiang H.Y., Wek S.A., McGrath B.C., Lu D., Hai T., Harding H.P., Wang X., Ron D., Cavener D.R., Wek R.C. Activating transcription factor 3 is integral to the eukaryotic initiation factor 2 kinase stress response. Molecular and Cellular Biology 2004, 24:1365-1377.
16. Karunakaran S., Saeed U., Mishra M., Valli R.K., Joshi S.D., Meka D.P., Seth P., Ravindranath V. Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice. Journal of Neuroscience 2008, 28:12500-12509.
17. Kim-Han J.S., Antenor-Dorsey J.A., O'Malley K.L. The parkinsonian mimetic, MPP+, specifically impairs mitochondrial transport in dopamine axons. Journal of Neuroscience 2011, 31:7212-7221.
18. Kook Y.H., Ka M., Um M. Neuroprotective cytokines repress PUMA induction in the 1-methyl-4-phenylpyridinium (MPP(+)) model of Parkinson's disease. Biochemical and Biophysical Research Communications 2011, 411:370-374.
19. Lotharius J., Dugan L.L., O'Malley K.L. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. Journal of Neuroscience 1999, 19:1284-1293.
20. Malhotra J.D., Kaufman R.J. The endoplasmic reticulum and the unfolded protein response. Seminars in Cell and Developmental Biology 2007, 18:716-731.
21. Malhotra J.D., Kaufman R.J. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword?. Antioxidants and Redox Signalling 2007, 9:2277-2293.
22. Mandavilli B.S., Ali S.F., Van Houten B. DNA damage in brain mitochondria caused by aging and MPTP treatment. Brain Research 2000, 885:45-52.
23. Mandir A.S., Simbulan-Rosenthal C.M., Poitras M.F., Lumpkin J.R., Dawson V.L., Smulson M.E., Dawson T.M. A novel in vivo post-translational modification of p53 by PARP-1 in MPTP-induced parkinsonism. Journal of Neurochemistry 2002, 83:186-192.
24. Markey S.P., Johannessen J.N., Chiueh C.C., Burns R.S., Herkenham M.A. Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism. Nature 1984, 311:464-467.
25. Nakano K., Vousden K.H. PUMA, a novel proapoptotic gene, is induced by p53. Molecular Cell 2001, 7:683-694.
26. O'Malley K.L., Liu J., Lotharius J., Holtz W. Targeted expression of BCL-2 attenuates MPP+ but not 6-OHDA induced cell death in dopaminergic neurons. Neurobiology of Disease 2003, 14:43-51.
27. Reimertz C., Kogel D., Rami A., Chittenden T., Prehn J.H. Gene expression during ER stress-induced apoptosis in neurons: induction of the BH3-only protein Bbc3/PUMA and activation of the mitochondrial apoptosis pathway. Journal of Cell Biology 2003, 162:587-597.
28. Ryu E.J., Harding H.P., Angelastro J.M., Vitolo O.V., Ron D., Greene L.A. Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. Journal of Neuroscience 2002, 22:10690-10698.
29. Sado M., Yamasaki Y., Iwanaga T., Onaka Y., Ibuki T., Nishihara S., Mizuguchi H., Momota H., Kishibuchi R., Hashimoto T., Wada D., Kitagawa H., Watanabe T.K. Protective effect against Parkinson's disease-related insults through the activation of XBP1. Brain Research 2009, 1257:16-24.
30. Snyder H., Wolozin B. Pathological proteins in Parkinson's disease: focus on the proteasome. Journal of Molecular Neuroscience 2004, 24:425-442.
31. Staal R.G., Sonsalla P.K. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata. Journal of Pharmacology and Experimental Therapeutics 2000, 293:336-342.
32. Sun X., Liu J., Crary J.F., Malagelada C., Sulzer D., Greene L.A., Levy O.A. ATF4 protects against neuronal death in cellular Parkinson's disease models by maintaining levels of parkin. Journal of Neuroscience 2013, 33:2398-2407.
33. Trimmer P.A., Smith T.S., Jung A.B., Bennett J.P. Dopamine neurons from transgenic mice with a knockout of the p53 gene resist MPTP neurotoxicity. Neurodegeneration 1996, 5:233-239.
34. Vila M., Jackson-Lewis V., Vukosavic S., Djaldetti R., Liberatore G., Offen D., Korsmeyer S.J., Przedborski S. Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:2837-2842.
35. Vila M., Przedborski S. Genetic clues to the pathogenesis of Parkinson's disease. Nature Medicine 2004, 10(Suppl.):S58-S62.
36. Wang H., Shimoji M., Yu S.W., Dawson T.M., Dawson V.L. Apoptosis inducing factor and PARP-mediated injury in the MPTP mouse model of Parkinson's disease. Annals of the New York Academy of Sciences 2003, 991:132-139.
37. Wu J., Kaufman R.J. From acute ER stress to physiological roles of the Unfolded Protein Response. Cell Death and Differentiation 2006, 13:374-384.
38. Yu J., Zhang L., Hwang P.M., Kinzler K.W., Vogelstein B. PUMA induces the rapid apoptosis of colorectal cancer cells. Molecular Cell 2001, 7:673-682.
39. Zhang K., Kaufman R.J. Protein folding in the endoplasmic reticulum and the unfolded protein response. Journal of Biological Chemistry 2004, 279:25935-25938.
40. Zhang K., Kaufman R.J. The unfolded protein response: a stress signaling pathway critical for health and disease. Neurology 2006, 66:S102-S109.